|

Empagliflozin 25 milgrams (Mg) Clinical Trials

1 actively recruiting trial

Also known as: Jardiance 25 Mg

Pipeline

Phase 2: 1

Top Sponsors

  • Instituto Nacional de Cardiologia Ignacio Chavez1

Indications

  • No-Reflow Phenomenon1
  • STEMI1
  • Heart Disease1

Other1 trial

Empagliflozin for No-reflow Phenomenon in PCI for STEMI
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.